- Home
- Clinical Trials
COVID-19 Antiviral Studies Hutt Valley
Clementine COVID-19 Antiviral Study
Hutt Valley
This clinical research study is evaluating a potential new antiviral treatment for COVID-19. Around 3,000 people around the world are taking part. We are looking for people at risk of severe illness from COVID-19. This can include people with a weakened immune system, high-risk medical conditions, or those who are over 75.
This can include but is not limited to:
- If you are over 75
- Having current or have had a recent cancer treatment, organ or stem cell transplants
- Those with immune disorders
- Taking immunosuppressive medications such as prednisone or treatments for rheumatoid conditions
- Have HIV with a low CD4 count
- Liver disease, blood disease, neurological conditions, kidney disease, or movement disorders
- People who are smokers
- People with Diabetes, chronic lung disease, heart disease, or obesity
Description
What to expect
Study details
Ages
18+
Duration
6-year duration with 6 clinic visits and 3 phone calls if you become symptomatic with COVID-19
Compensation
$150 per clinic visit and $75 per virtual visit or phone call
Eligibility Criteria
- Aged 18+ and immunocompromised and at an increased risk of severe illness from COVID-19.
- Or adults 75+
Locations
Description
For a range of health reasons, some people at risk of severe illness from COVID-19 may not be able to access currently approved COVID-19 treatments. Taking part in this study involves an investigational medication, meaning that it is not yet approved for use in New Zealand.
What does taking part in the study involve?
If you choose to take part in the study, we would like to follow your health over a period of up to 6 years. Over this time, we keep in regular contact with you. If you develop COVID-19 symptoms at any point during this 6-year period, we would like to see you as soon as possible to check up on your health. At this time, your study doctor will work closely with your GP and your health professionals to check to see if a currently approved antiviral treatment option for COVID-19 is available, safe, and appropriate for you. We also make sure your GP and other health providers know that you are unwell and keep in close contact with your normal care team for any health concerns.
Participating with COVID-19 symptoms means taking the investigational treatment or a placebo (like the investigational medication but with no active ingredient) within 4 days of your symptom onset.
- Two tablets are taken by mouth 2 times daily for 5 days.
- We ask you to visit the study clinic 3 times over the 5 days, with 3 more visits on days 10, 14 and 29.
- If you are very unwell, the study Doctors can attend at your home.
- We also would like to contact you by phone after 8, 16 and 24 weeks.
What to expect
What is the study aiming to prove?
The study is testing to find out how well the investigational medication works, compared to the placebo, in terms of:
- The safety of the investigational medication
- Reducing symptoms of COVID-19
- Preventing Long COVID-19
- Lowering the level of COVID-19 virus in the body
- Preventing hospitalisation, significant serious illness, or death from COVID-19
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research NZ is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.